{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "binds",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P40933",
      "entity_text" : "pIL15",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:P28067",
      "entity_text" : "DMA",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false,
    "context" : {
      "TissueType" : [ "tissuelist:TS-0160" ],
      "Cellular_component" : [ "go:GO:0018995" ],
      "Organ" : [ "uberon:UBERON:0002405" ],
      "Species" : [ "taxonomy:10090" ],
      "CellType" : [ "cl:CL:0000542" ]
    }
  },
  "verbose_text" : "Treatment of tumor bearing mice with DMA - pIL15 complex significantly inhibited tumor growth in both subcutaneous and peritoneal models in vivo by inhibiting angiogenesis, promoting apoptosis, and reducing proliferation through activation of the host immune system.",
  "reading_complete" : "2020-08-02T12:06:45Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T12:05:43Z",
  "trigger" : "complex",
  "evidence" : [ "DMA-pIL15 complex" ],
  "pmc_id" : "6037032",
  "score" : 0
}